BioWorld

March 1, 2002

View Archived Issues

Centocor’s Remicade Receives Third Rheumatoid Arthritis Nod

Centocor Inc.’s Remicade is inflating - both in uses and sales - having received a third approval in a rheumatoid arthritis indication. (BioWorld Today) Read More

FDA Panel Agrees To Corixa’s Melacine Phase III Study Protocol

Read More

How Mutated Tumor-Suppressor Gene May Influence Burgeoning Anti-Angiogenic Drug Treatment

Read More

Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study

Read More

Other News To Note

Read More

Gen-Probe, Chiron Gain Approval For HIV, HCV Nucleic Acid Tests

Read More

Appointments And Advancements

Read More